NexPlasmaGen featured in the Profit TRIBUNE magazine | NexPlasmaGen
17378
post-template-default,single,single-post,postid-17378,single-format-standard,bridge-core-2.6.4,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-theme-ver-24.9,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,qode-wpml-enabled,wpb-js-composer js-comp-ver-7.7,vc_responsive

NexPlasmaGen featured in the Profit TRIBUNE magazine

19 Jun NexPlasmaGen featured in the Profit TRIBUNE magazine

Posted at 18:03h in Uncategorized by
0 Likes

Montreal / June 19, 2026

NexPlasmaGen is honored to have been published in the Profit TRIBUNE magazine.

https://profittribune.com/nexplasmagens-cold-plasma-breakthrough-aims-to-transform-breast-cancer-surgery-and-reduce-recurrence-worldwide/

ABOUT PROFIT TRIBUNE

Profit Tribune Magazine is a digital business publication that features interviews, startup spotlights, investment insights, and trend analyses aimed at entrepreneurs and growth‑focused professionals. It regularly covers topics such as financial strategies, real estate investing, digital banking trends, and profiles of emerging companies, presenting practical guidance and thought‑leadership pieces designed to help readers navigate modern business challenges and opportunities.

ABOUT NEXPLASMAGEN

NexPlasmaGen converges the emerging field of cold plasma biotechnology towards personalized cancer treatment. We develop high-precision cold plasma systems that destroy cancer cells while sparing the healthy tissue. The first application of NexPlasmaGen is the treatment of breast cancer, followed by skin and lung cancer. Its patented cold plasma medical device has the potential to reduce the rate of cancer recurrence as well as side effects and toxicity of the standard of care for the benefit of patients.

Contact :

Dr. Valérie Léveillé, ing., M.Sc.A., CEO/Founder

Tel. : 1-514-229-9458

Email : valerie.leveille@nexplasmagen.com

Website : https://nexplasmagen.com/

No Comments

Post A Comment